BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishikawa N, Oguri T, Isobe T, Fujitaka K, Kohno N. SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn J Cancer Res. 2001;92:874-879. [PMID: 11509120 DOI: 10.1111/j.1349-7006.2001.tb01175.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Chou CW, Wu MS, Huang WC, Chen CC. HDAC inhibition decreases the expression of EGFR in colorectal cancer cells. PLoS One 2011;6:e18087. [PMID: 21464950 DOI: 10.1371/journal.pone.0018087] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
2 Wang L, Liu M, Yin F, Wang Y, Li X, Wu Y, Ye C, Liu J. Trilobatin, a Novel SGLT1/2 Inhibitor, Selectively Induces the Proliferation of Human Hepatoblastoma Cells. Molecules 2019;24:E3390. [PMID: 31540429 DOI: 10.3390/molecules24183390] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Guo GF, Cai YC, Zhang B, Xu RH, Qiu HJ, Xia LP, Jiang WQ, Hu PL, Chen XX, Zhou FF, Wang F. Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis. Med Oncol 2011;28 Suppl 1:S197-203. [PMID: 21080109 DOI: 10.1007/s12032-010-9696-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
4 Baker EH, Wood DM, Brennan AL, Clark N, Baines DL, Philips BJ. Hyperglycaemia and pulmonary infection. Proc Nutr Soc 2006;65:227-35. [PMID: 16923307 DOI: 10.1079/pns2006499] [Cited by in Crossref: 54] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
5 Helmke BM, Reisser C, Idzko M, Dyckhoff G, Herold-Mende C. Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck. Oral Oncol 2004;40:28-35. [PMID: 14662412 DOI: 10.1016/s1368-8375(03)00129-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
6 Wright EM, Loo DD, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev. 2011;91:733-794. [PMID: 21527736 DOI: 10.1152/physrev.00055.2009] [Cited by in Crossref: 743] [Cited by in F6Publishing: 659] [Article Influence: 67.5] [Reference Citation Analysis]
7 Dransfeld O, Gehrmann T, Köhrer K, Kircheis G, Holneicher C, Häussinger D, Wettstein M. Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver. Liver Int. 2005;25:1243-1258. [PMID: 16343078 DOI: 10.1111/j.1478-3231.2005.01158.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
8 Perry RJ, Shulman GI. Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks. J Biol Chem 2020;295:14379-90. [PMID: 32796035 DOI: 10.1074/jbc.REV120.008387] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Leslie TK, James AD, Zaccagna F, Grist JT, Deen S, Kennerley A, Riemer F, Kaggie JD, Gallagher FA, Gilbert FJ, Brackenbury WJ. Sodium homeostasis in the tumour microenvironment. Biochim Biophys Acta Rev Cancer 2019;1872:188304. [PMID: 31348974 DOI: 10.1016/j.bbcan.2019.07.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
10 Elliott RH, Matthews VB, Rudnicka C, Schlaich MP. Is it time to think about the sodium glucose co-transporter 2 sympathetically? Nephrology (Carlton) 2016;21:286-94. [PMID: 26369359 DOI: 10.1111/nep.12620] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
11 Oehr P. Transport and Metabolism of Glucose and FDG. PET and PET-CT in Oncology. Berlin: Springer Berlin Heidelberg; 2004. pp. 29-42. [DOI: 10.1007/978-3-642-18803-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Patra M, Johnstone TC, Suntharalingam K, Lippard SJ. A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells. Angew Chem Int Ed Engl 2016;55:2550-4. [PMID: 26749149 DOI: 10.1002/anie.201510551] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 16.0] [Reference Citation Analysis]
13 Sharma B, Singh S, Kanwar SS. L-methionase: a therapeutic enzyme to treat malignancies. Biomed Res Int 2014;2014:506287. [PMID: 25250324 DOI: 10.1155/2014/506287] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Oliveira TL, Candeia-Medeiros N, Cavalcante-Araújo PM, Melo IS, Fávaro-Pípi E, Fátima LA, Rocha AA, Goulart LR, Machado UF, Campos RR, Sabino-Silva R. SGLT1 activity in lung alveolar cells of diabetic rats modulates airway surface liquid glucose concentration and bacterial proliferation. Sci Rep 2016;6:21752. [PMID: 26902517 DOI: 10.1038/srep21752] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
15 Casneuf VF, Fonteyne P, Van Damme N, Demetter P, Pauwels P, de Hemptinne B, De Vos M, Van de Wiele C, Peeters M. Expression of SGLT1, Bcl-2 and p53 in Primary Pancreatic Cancer Related to Survival. Cancer Investigation 2009;26:852-9. [DOI: 10.1080/07357900801956363] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
16 Coady MJ, El Tarazi A, Santer R, Bissonnette P, Sasseville LJ, Calado J, Lussier Y, Dumayne C, Bichet DG, Lapointe JY. MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2. J Am Soc Nephrol 2017;28:85-93. [PMID: 27288013 DOI: 10.1681/ASN.2015111282] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 6.2] [Reference Citation Analysis]
17 Patra M, Johnstone TC, Suntharalingam K, Lippard SJ. A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells. Angew Chem 2016;128:2596-600. [DOI: 10.1002/ange.201510551] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
18 Ribeiro Morais G, Falconer RA, Santos I. Carbohydrate-Based Molecules for Molecular Imaging in Nuclear Medicine: Carbohydrates in Nuclear Medicine. Eur J Org Chem 2013;2013:1401-14. [DOI: 10.1002/ejoc.201201457] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
19 Koepsell H. The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer. Pharmacology & Therapeutics 2017;170:148-65. [DOI: 10.1016/j.pharmthera.2016.10.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
20 Lang F, Singh Y, Salker MS, Ma K, Pandyra AA, Lang PA, Lang KS. Glucose transport in lymphocytes. Pflugers Arch 2020;472:1401-6. [PMID: 32529300 DOI: 10.1007/s00424-020-02416-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Leiprecht N, Munoz C, Alesutan I, Siraskar G, Sopjani M, Föller M, Stubenrauch F, Iftner T, Lang F. Regulation of Na(+)-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein. Biochem Biophys Res Commun 2011;404:695-700. [PMID: 21156162 DOI: 10.1016/j.bbrc.2010.12.044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
22 Yang L, Liang Q, Shen K, Ma L, An N, Deng W, Fei Z, Liu J. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells. Biomedicine & Pharmacotherapy 2015;71:70-8. [DOI: 10.1016/j.biopha.2015.02.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
23 Yamazaki Y, Harada S, Tokuyama S. Sodium-glucose transporter as a novel therapeutic target in disease. Eur J Pharmacol 2018;822:25-31. [PMID: 29329760 DOI: 10.1016/j.ejphar.2018.01.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
24 Huber SM, Butz L, Stegen B, Klumpp D, Braun N, Ruth P, Eckert F. Ionizing radiation, ion transports, and radioresistance of cancer cells. Front Physiol 2013;4:212. [PMID: 23966948 DOI: 10.3389/fphys.2013.00212] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
25 Rexhepaj R, Rotte A, Gu S, Michael D, Pasham V, Wang K, Kempe DS, Ackermann TF, Brücher B, Fend F, Föller M, Lang F. Tumor suppressor gene adenomatous polyposis coli downregulates intestinal transport. Pflugers Arch - Eur J Physiol 2011;461:527-36. [DOI: 10.1007/s00424-011-0945-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ehrenkranz J. Glucose control, the kidney, and potential treatments for diabetes: more to the story. Am J Kidney Dis 2009;54:583. [PMID: 19700067 DOI: 10.1053/j.ajkd.2009.06.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Huber SM. Oncochannels. Cell Calcium 2013;53:241-55. [DOI: 10.1016/j.ceca.2013.01.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
28 Pakladok T, Hosseinzadeh Z, Alesutan I, Lang F. Stimulation of the Na+-coupled glucose transporter SGLT1 by B-RAF. Biochemical and Biophysical Research Communications 2012;427:689-93. [DOI: 10.1016/j.bbrc.2012.09.062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
29 Lai B, Xiao Y, Pu H, Cao Q, Jing H, Liu X. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma. Arch Gynecol Obstet 2012;285:1455-61. [DOI: 10.1007/s00404-011-2166-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
30 Philips BJ, Meguer JX, Redman J, Baker EH. Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med 2003;29:2204-10. [PMID: 14647890 DOI: 10.1007/s00134-003-1961-2] [Cited by in Crossref: 119] [Cited by in F6Publishing: 117] [Article Influence: 6.3] [Reference Citation Analysis]
31 Calvo MB, Figueroa A, Pulido EG, Campelo RG, Aparicio LA. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010;2010. [PMID: 20706540 DOI: 10.1155/2010/205357] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 7.8] [Reference Citation Analysis]
32 Szablewski L. Expression of glucose transporters in cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013;1835:164-9. [DOI: 10.1016/j.bbcan.2012.12.004] [Cited by in Crossref: 130] [Cited by in F6Publishing: 203] [Article Influence: 14.4] [Reference Citation Analysis]
33 Huber SM, Butz L, Stegen B, Klumpp L, Klumpp D, Eckert F. Role of ion channels in ionizing radiation-induced cell death. Biochimica et Biophysica Acta (BBA) - Biomembranes 2015;1848:2657-64. [DOI: 10.1016/j.bbamem.2014.11.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
34 Wu WZ, Sun HC, Wang L, Chen J, Liu KD, Tang ZY. Modulation of gene expression in MHCC97 cells by interferon alpha. World J Gastroenterol 2005; 11(42): 6613-6619 [PMID: 16425353 DOI: 10.3748/wjg.v11.i42.6613] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Wang J, Ji H, Niu X, Yin L, Wang Y, Gu Y, Li D, Zhang H, Lu M, Zhang F, Zhang Q. Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer. Dis Markers 2020;2020:6103542. [PMID: 32377271 DOI: 10.1155/2020/6103542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Geddes DM, Hodson ME, Baker EH. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. Journal of Cystic Fibrosis 2007;6:101-9. [DOI: 10.1016/j.jcf.2006.03.009] [Cited by in Crossref: 117] [Cited by in F6Publishing: 103] [Article Influence: 7.8] [Reference Citation Analysis]
37 Madunić IV, Madunić J, Breljak D, Karaica D, Sabolić I. Sodium-glucose cotransporters: new targets of cancer therapy? Arh Hig Rada Toksikol 2018;69:278-85. [PMID: 30864374 DOI: 10.2478/aiht-2018-69-3204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
38 Hosseinzadeh Z, Bhavsar SK, Shojaiefard M, Saxena A, Merches K, Sopjani M, Alesutan I, Lang F. Stimulation of the glucose carrier SGLT1 by JAK2. Biochemical and Biophysical Research Communications 2011;408:208-13. [DOI: 10.1016/j.bbrc.2011.03.036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
39 Garcke H, Lam KF, Sitka E, Styles V. A Cahn–Hilliard–Darcy model for tumour growth with chemotaxis and active transport. Math Models Methods Appl Sci 2016;26:1095-148. [DOI: 10.1142/s0218202516500263] [Cited by in Crossref: 66] [Article Influence: 11.0] [Reference Citation Analysis]
40 Martinez CA, Scafoglio C. Heterogeneity of Glucose Transport in Lung Cancer. Biomolecules 2020;10:E868. [PMID: 32517099 DOI: 10.3390/biom10060868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Kobayashi M, Uematsu T, Tokura Y, Takei K, Sakamoto K, Narimatsu T, Nukui A, Kamai T. Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications. Int Braz J Urol 2019;45:169-78. [PMID: 30521176 DOI: 10.1590/S1677-5538.IBJU.2018.0271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
42 Lin HW, Tseng CH. A Review on the Relationship between SGLT2 Inhibitors and Cancer. Int J Endocrinol 2014;2014:719578. [PMID: 25254045 DOI: 10.1155/2014/719578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
43 Cangoz S, Chang Y, Chempakaseril SJ, Guduru RC, Huynh LM, John JS, John ST, Joseph ME, Judge R, Kimmey R, Kudratov K, Lee PJ, Madhani IC, Shim PJ, Singh S, Singh S, Ruchalski C, Raffa RB. The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors. J Clin Pharm Ther 2013;38:350-9. [DOI: 10.1111/jcpt.12077] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
44 Mumcuoglu D, Sardan Ekiz M, Gunay G, Tekinay T, Tekinay AB, Guler MO. Cellular Internalization of Therapeutic Oligonucleotides by Peptide Amphiphile Nanofibers and Nanospheres. ACS Appl Mater Interfaces 2016;8:11280-7. [PMID: 27097153 DOI: 10.1021/acsami.6b01526] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
45 Faillie J. Pharmacological aspects of the safety of gliflozins. Pharmacological Research 2017;118:71-81. [DOI: 10.1016/j.phrs.2016.07.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
46 Song Z, Zhu J, Wei Q, Dong G, Dong Z. Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 2020;318:F1041-52. [PMID: 32150448 DOI: 10.1152/ajprenal.00512.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
47 Mojica L, Luna-Vital DA, Gonzalez de Mejia E. Black bean peptides inhibit glucose uptake in Caco-2 adenocarcinoma cells by blocking the expression and translocation pathway of glucose transporters. Toxicol Rep 2018;5:552-60. [PMID: 29854625 DOI: 10.1016/j.toxrep.2018.04.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
48 Elvira B, Honisch S, Almilaji A, Pakladok T, Liu G, Shumilina E, Alesutan I, Yang W, Munoz C, Lang F. Up-regulation of Na(+)-coupled glucose transporter SGLT1 by caveolin-1. Biochim Biophys Acta 2013;1828:2394-8. [PMID: 23774524 DOI: 10.1016/j.bbamem.2013.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
49 Huber SM, Misovic M, Mayer C, Rodemann HP, Dittmann K. EGFR-mediated stimulation of sodium/glucose cotransport promotes survival of irradiated human A549 lung adenocarcinoma cells. Radiother Oncol 2012;103:373-9. [PMID: 22516777 DOI: 10.1016/j.radonc.2012.03.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
50 Scafoglio CR, Villegas B, Abdelhady G, Bailey ST, Liu J, Shirali AS, Wallace WD, Magyar CE, Grogan TR, Elashoff D, Walser T, Yanagawa J, Aberle DR, Barrio JR, Dubinett SM, Shackelford DB. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. Sci Transl Med 2018;10:eaat5933. [PMID: 30429355 DOI: 10.1126/scitranslmed.aat5933] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
51 Chuang CY, Tang CM, Ho HY, Hsin CH, Weng CJ, Yang SF, Chen PN, Lin CW. Licochalcone A induces apoptotic cell death via JNK/p38 activation in human nasopharyngeal carcinoma cells. Environ Toxicol 2019;34:853-60. [PMID: 30983163 DOI: 10.1002/tox.22753] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
52 Taira N, Atsumi E, Nakachi S, Takamatsu R, Yohena T, Kawasaki H, Kawabata T, Yoshimi N. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the 18F-FDG PET/CT mediastinal nodal staging of non-small cell lung cancer. Lung Cancer 2018;123:30-5. [PMID: 30089592 DOI: 10.1016/j.lungcan.2018.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
53 de Geus-oei L, Krieken JHJV, Aliredjo RP, Krabbe PF, Frielink C, Verhagen AF, Boerman OC, Oyen WJ. Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007;55:79-87. [DOI: 10.1016/j.lungcan.2006.08.018] [Cited by in Crossref: 133] [Cited by in F6Publishing: 128] [Article Influence: 8.9] [Reference Citation Analysis]
54 Patra M, Awuah SG, Lippard SJ. Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo. J Am Chem Soc 2016;138:12541-51. [PMID: 27570149 DOI: 10.1021/jacs.6b06937] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 13.2] [Reference Citation Analysis]